GI Dynamics diabetic device shows positive study results
GI Dynamics Inc. [1], a Lexington medical device firm, has announced results of three studies of its EndoBarrier Gastrointestinal Liner in treating type 2 diabetes and obesity.
The EndoBarrier, inserted in the GI tract endoscopically, was found to improve glycemic control and weight loss, according to a news release [2] from the company. The study involved 17 obese patients using the implanted EndoBarrier for 24 weeks.
SOURCE [3]